Michael E. Goldberg is David Mahoney Professor of Brain and Behavior in the departments of neuroscience, neurology, psychiatry and ophthalmology at Columbia University College of Physicians and Surgeons, director of the Mahoney-Keck Center for Brain and Behavior Research, and is an active clinical neurologist. His neuroscience research focuses on the physiological basis of cognitive processes such as visual attention, spatial perception and decision-making. He earned his M.D. from Harvard Medical School in 1968. From 1978 to 2001, Goldberg was a senior investigator at the Laboratory of Sensorimotor Research at the National Eye Institute in Bethesda, Maryland. He is a fellow of the American Academy of Arts and Sciences and the American Association for the Advancement of Science, and an elected member of the National Academy of Sciences. He is a past president of the Society for Neuroscience, and now chair of the society’s Committee on Animals in Research.
Michael E. Goldberg
David Mahoney Professor of Brain and Behavior
Columbia University
Explore more from The Transmitter
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Measuring plastic in the brain: Improving, but incomplete
Meanwhile, researchers are publishing papers without “sufficient quality control,” says analytical chemist Dušan Materić.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Incredible shrinking grant deadlines at the BRAIN Initiative
“A month is crazy,” says one former recipient, referring to a new funding opportunity’s timeline.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.